Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
628 hedge funds and large institutions have $33.3B invested in Allergan plc in 2014 Q1 according to their latest regulatory filings, with 118 funds opening new positions, 221 increasing their positions, 236 reducing their positions, and 36 closing their positions.
228% more first-time investments, than exits
New positions opened: 118 | Existing positions closed: 36
86% more call options, than puts
Call options by funds: $918M | Put options by funds: $493M
38% more funds holding in top 10
Funds holding in top 10: 53 → 73 (+20)
34% more capital invested
Capital invested by funds: $24.9B → $33.3B (+$8.39B)
14% more funds holding
Funds holding: 552 → 628 (+76)
6% less repeat investments, than reductions
Existing positions increased: 221 | Existing positions reduced: 236
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TP
Third Point
New York
|
+$495M |
| 2 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
+$471M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$448M |
| 4 |
TIM
Thornburg Investment Management
Santa Fe,
New Mexico
|
+$415M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$201M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$365M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$195M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$164M |
| 4 |
RIM
Rainier Investment Management
Seattle,
Washington
|
-$136M |
| 5 |
HCM
Hoplite Capital Management
New York
|
-$114M |
AGN Hedge Fund Activity: Q1 2014 in Review
628 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q1 2014, worth a combined $33.3B — up 34% from $24.9B a quarter earlier.
Buyers outnumbered sellers: 118 funds opened new AGN positions and 36 closed out — a net gain of 82 holders — while 221 added to existing stakes and 236 trimmed.
The largest buyer was Third Point, opening a new position worth an estimated $495M. The largest seller was Viking Global Investors, cutting an estimated $365M.
- 628 institutional investors held Allergan plc (AGN) as of Q1 2014, up from 552 in Q4 2013.
- Funds reported $33.3B of Allergan plc stock for Q1 2014, up 34% quarter-over-quarter.
- 118 funds opened new Allergan plc positions in Q1 2014 and 36 closed out, a net change of +82 holders.
- The largest Allergan plc buyer in Q1 2014 was Third Point, an estimated $495M added.
- The largest Allergan plc seller in Q1 2014 was Viking Global Investors, an estimated $365M sold.
Based on aggregated 13F filings for Q1 2014.